https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-482013-08-14 00:00:002021-11-15 14:43:30Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2013-04-12 17:22:322019-02-12 17:22:47Science kürt Immuntherapie gegen Krebs 2013 zum „Breakthrough of the Year“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-02-01 / BioDrugs 2013 Feb;27(1):35-53https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-02-01 / BioDrugs 2013 Feb;27(1):35-532013-02-01 00:00:002021-11-15 16:56:59Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-442012-04-22 00:00:002021-11-15 14:43:58Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function
/in Colorectal Cancer, Dendritic Cells, International Publications, IOZK VeröffentlichungenMyeloid-derived suppressor cells in glioma
/in Glioblastoma, International Publications, IOZK VeröffentlichungenDendritic cell-based immunotherapy in ovarian cancer
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian CancerImmunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials
/in Glioblastoma, International Publications, IOZK VeröffentlichungenImmunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian CancerFormulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
/in Glioblastoma, International Publications, IOZK VeröffentlichungenOncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusScience kürt Immuntherapie gegen Krebs 2013 zum „Breakthrough of the Year“
/in Externe MeldungenBispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease VirusIntegration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen